The current landscape The landscape of dementia clinical trials in Europe is focused on AD, the most common form of dementia.

Skyhawk Therapeutics has announced positive interim results from its phase 1 trial of SKY-0515, an investigational treatment ...

Boehringer Ingelheim and Simcere have announced a new license and collaboration agreement for the development of SIM0709, a ...

AstraZeneca and CSPC Pharmaceuticals have announced a new collaboration agreement for the development of therapies for obesity and type 2 diabetes.

Grounded in data-driven human insights and representing the perspectives of both patients and HCPs, medical affairs can ...

GC Therapeutics has appointed Kate Haviland as Board Chair.

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with ...

GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that ...